Tonix Pharmaceuticals (NASDAQ: TNXP) released selected preliminary financial results for 2024, reporting approximately $98.8 million in cash and cas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback